A Phase 2b Study of JZP-385 for the Potential Treatment of Essential Tremor
Latest Information Update: 09 Aug 2021
At a glance
- Drugs Suvecaltamide (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 03 Aug 2021 According to a Jazz Pharmaceuticals media release, the company expects to initiate this study in late 2021.
- 07 Jun 2021 New trial record
- 23 Feb 2021 According to a Jazz Pharmaceuticals media release, the company expects to initiate this Phase 2b trial in mid-2021.